Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kagan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Cell Science|February 19, 2004
Microtubule motors control membrane dynamics of Salmonella-containing vacuolesJulie Guignot, Emmanuelle Caron, Carmen Beuzón, et al.
Journal of Virology|August 17, 2012
Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirusPalanivel Velupillai, Chang Kyoo Sung, Erik Andrews, et al.
Public Health Reports (Washington, D.C. : 1974)|June 3, 2016
Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing CountriesJonathan Kagan, Dao Duc Giang, Michael F Iademarco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infectionDonna Mildvan, John Spritzler, Sidney E Grossberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2003
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials GroupJohn Spritzler, Donna Mildvan, Aleksandra Russo, et al.
Clinical Trials (London, England)|October 25, 2019
A randomized evaluation of on-site monitoring nested in a multinational randomized trialNicole Wyman Engen, Kathy Huppler Hullsiek, Waldo H Belloso, et al.
Lancet (London, England)|January 14, 2014
Increasing value and reducing waste in biomedical research regulation and managementRustam Al-Shahi Salman, Elaine Beller, Jonathan Kagan, et al.
AIDS and Behavior|June 26, 2014
ACT2 peer-driven intervention increases enrollment into HIV/AIDS medical studies among African Americans/Blacks and Hispanics: A cluster randomized controlled trialMarya Gwadz, Charles M Cleland, Mindy Belkin, et al.
The Journal of Infectious Diseases|May 4, 2004
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment responseDonna Mildvan, Ronald J Bosch, Ryung S Kim, et al.
Contemporary Clinical Trials Communications|November 3, 2021
Strategy management in collaborative clinical research partnershipsJonathan Kagan, Jerome Lassa, Judith Zuckerman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Cell Science|February 19, 2004
Microtubule motors control membrane dynamics of Salmonella-containing vacuolesJulie Guignot, Emmanuelle Caron, Carmen Beuzón, et al.
Journal of Virology|August 17, 2012
Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirusPalanivel Velupillai, Chang Kyoo Sung, Erik Andrews, et al.
Public Health Reports (Washington, D.C. : 1974)|June 3, 2016
Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing CountriesJonathan Kagan, Dao Duc Giang, Michael F Iademarco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infectionDonna Mildvan, John Spritzler, Sidney E Grossberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2003
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials GroupJohn Spritzler, Donna Mildvan, Aleksandra Russo, et al.
Clinical Trials (London, England)|October 25, 2019
A randomized evaluation of on-site monitoring nested in a multinational randomized trialNicole Wyman Engen, Kathy Huppler Hullsiek, Waldo H Belloso, et al.
Lancet (London, England)|January 14, 2014
Increasing value and reducing waste in biomedical research regulation and managementRustam Al-Shahi Salman, Elaine Beller, Jonathan Kagan, et al.
AIDS and Behavior|June 26, 2014
ACT2 peer-driven intervention increases enrollment into HIV/AIDS medical studies among African Americans/Blacks and Hispanics: A cluster randomized controlled trialMarya Gwadz, Charles M Cleland, Mindy Belkin, et al.
The Journal of Infectious Diseases|May 4, 2004
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment responseDonna Mildvan, Ronald J Bosch, Ryung S Kim, et al.
Contemporary Clinical Trials Communications|November 3, 2021
Strategy management in collaborative clinical research partnershipsJonathan Kagan, Jerome Lassa, Judith Zuckerman, et al.
Pageof 2